Journal of Polymer Science Part A Polymer Chemistry · 2013 · 71 citations · 20 references
PharmacyPharmaceuticsToxicologyBiocompatibilityDrug DeliveryPolymer ChemistryCytotoxicity AssessmentCytotoxicity EvaluationPolymeric Drug Delivery SystemsBiomedical ApplicationsCell Viability AssaysCytotoxicity AssaysHemolysis AssaysMolar MassPolymer BiocompatibilityPolymer ToxicityRed Blood Cell Aggregation
Abstract Since poly(2‐methyl‐2‐oxazolines) (PMeOx) attract high attention for the potential use in drug delivery, cytotoxicity, and hemocompatibility of a set of PMeOxs with molar masses in the range from 2 to 20 kDa are systematically investigated under standardized conditions in terms of molar mass, concentration and time dependency. PMeOx polymers are well tolerated in red blood cell aggregation and hemolysis assays without any damaging effects even at high concentrations up to 80 mg/mL. Only in long term cytotoxicity tests PMeOx polymers moderately influence cell viability in a time, concentration, and molar mass dependent manner. Referring to these results it can be concluded that PEtOx could be promising nonionic hydrophilic polymers for many biomedical applications without any cyto‐ and hemotoxic effects at typically used therapeutic doses. © 2013 Wiley Periodicals, Inc. J Polym Sci Part A: Polym Chem, 2013
20
Holger Petersen, Petra M. Fechner, Alison Martin et al. · Bioconjugate Chemistry · 2002 · 533 citations
Polyoxazoline: Chemistry, Properties, and Applications in Drug Delivery
Tacey X. Viegas, Michael D. Bentley, J. Milton Harris et al. · Bioconjugate Chemistry · 2011 · 423 citations